United Hydrogen Group, Inc. agreed to acquire Aimei Health Technology Co., Ltd (NasdaqGM:AFJK) in a reverse merger transaction on June 19, 2024. The transaction has been approved by each of AFJK?s and United Hydrogen?s Board of Directors and is subject the approval of AFJK?s shareholders and United Hydrogen?s shareholders, effectiveness of the Registration Statement in accordance with the Securities Act of 1933, receipt of all necessary approvals from the China Securities Regulatory Commission in connection with the Transactions; and necessary consents, approvals and authorizations, including but not limited to, regulatory approval by Nasdaq and the U.S. Securities and Exchange Commission, necessary third-party approvals and the expiration of any waiting period under the Hart-Scott-Rodino Act, if applicable, receipt of all approvals, waivers or consents from any third parties and the satisfaction or waiver of other customary closing conditions. The transaction is expected to close in the third quarter of 2024.

Ying Li, Esq and Guillaume de Sampigny of Hunter Taubman Fischer & Li LLC, Ogier (Cayman) LLP and Grandall Law Firm are acting as legal advisors to AFJK. Meng (Mandy) Lai of MagStone Law, LLP, Harneys and Yongxing Law Firm are acting as legal advisors to United Hydrogen. Chain Stone Capital Limited (CTM) is acting as financial advisor to United Hydrogen.